PRIZE. Hlin Kvartsberg’s dissertation, where she identifies a new biomarker for Alzheimer’s disease, has been named Sahlgrenska Academy’s 2019 PhD Thesis of the Year. “It feels amazing! The dissertation is the result of nearly four years of hard work, which I’m very proud of it, so it feels wonderful that it is recognized in this way,” says Hlin Kvartsberg. What are you most proud of about your dissertation? “That…
New blood test for Alzheimer’s developed
STUDY. A new blood test for Alzheimer’s disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, which makes the test relatively simple and cheap to perform. The research behind the test was headed by Kaj Blennow, Professor of Clinical Neurochemistry, and Henrik Zetterberg, Professor of Neurochemistry, at Sahlgrenska Academy,…
A first for online thesis defence
COVID-19. When Tugce Satir defended his thesis on March 20 the eternal reviewer was in Finland and one member of the examining committee was in Lund. – Family and friends back home in Turkey followed the proceedings through a link open to the public. It all went very well, but obviously it would have been better if we all could have been here together. The fact that amyloid beta plaque…
Akademiliv the Podcast (in Swedish) – hear Kaj Blennow on Alzheimer’s disease
PODCAST. Akademiliv the Podcast is back, this time we visit Kaj Blennow, Professor of Neurochemistry, for a talk on research methods, biomarkers and the hunt for the cure of Alzheimer’s disease. Along with his colleague Henrik Zetterberg, Kaj Blennow leads one of the most successful research groups at University of Gothenburg. They develop methods that make it possible to measure and monitor how Alzheimer’s disease develops in the human brain,…
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Makes Major Investment to Fast Track Development of Novel Biomarkers
GRANT. Professor Henrik Zetterberg at the University of Gothenburg will head a major European research collaboration, which is developing a significantly easier way to diagnose Alzheimer’s disease at an early stage through a blood test. Such a test could offer the potential for developing new treatments for Alzheimer’s and related dementias. . Through its Diagnostics Accelerator, the Alzheimer’s Drug Discovery Foundation (ADDF) – a U.S. based non-profit – is committed…